Dissertation > Excellent graduate degree dissertation topics show

The Myocardial Protection Effect of High-Dose Atorvastatin Pretreatment Before Percutaneous Coronary Intervention in Acute Coronary Syndrome

Author: ZhaoHongYan
Tutor: ChengBiao
School: Zunyi Medical College,
Course: Department of Cardiology
Keywords: Atorvastatin Soluble CD40 ligand (sCD40L) Acute coronary syndrome (ACS) Percutaneous coronary intervention(PCI) Myocardial protection effects
CLC: R541.4
Type: Master's thesis
Year: 2011
Downloads: 18
Quote: 0
Read: Download Dissertation


Objective:To observe the change of soluble CD40 ligand (sCD40L), highly sensitive C-reactive protein (hs-CRP) in preoperative and postoperative,and investigate the myocardial protection effect of a single high-dose (80mg) atorvastatin intensive treatment before percutaneous coronary intervention(PCI) in acute coronary syndrome (ACS) patients with the conventional atorvastatin (20mg/qn).Methods:The day before PCI,60 ACS patients were randomly divided into control group (atorvastatin 20mg/qn, n=30) and intensive group (atorvastatin 80mg12h before PCI, n=30). sCD40L, hs-CRP, creatine kinase-myocardial isoenzyme (CK-MB), car-diac troponin I (cTnI) were assessed before and 24 and 48h after PCI. The incidence of perioperative myocardial infarction (MI) and major adverse cardiac events(MACEs) were compared during 30-day follow-up.Results:(1)The sCD40L level was not statistically significant (P>0.05) on 24 and 48h after PCI in intensive treatment group.In the control group, the sCD40L level elevated 24h after PCI(1649.00±1031.75 vs 1220.00±756.91, P<0.01, but there was no significant difference 48h after PCI 1087.92±603.81 vs1220.00±756.91, P>0.05). (2) There was significant difference about the hs-CRP level between preoperative and postoperative in two groups (P<0.001).The elevation degree of hs-CRP in the intensive group was significanily lower compared with control group (4.80 vs 8.03, P<0.05). (3) 24h after PCI the levels of cTnI,CK-MB were significantly higher than preoperative (P<0.001).The cTnI and sD40L (r=0.313, P=0.023),cTnI and hs-CRP (r=0.288, P=0.033) had positive correlation perspectively. The CK-MB and sD40L (r=0.421,P=0.001),CK-MB and hs-CRP (r=0.283, P=0.030) had positive correlation perspectively. (4)The incidence of cTnI elevation> 3xupper limit of normal(ULN) was 3.33%(1 of 30) in intensive group and 10.00%(3 of 30) in control group. The incidence of CK-MB elevation>3xULN was 6.67%(2 of 30) in intensive groups and 10.00%(3 of 30) in control group. (p>0.05).(5)There were no changes of AST, ALT, Cr, CK before and after treatment in two groups.(6)There were no MACEs in 30-day follow-up.Conlusions:(1)The inflammation and platelet activation caused by PCI,preoperative strengthen preventive anti-inflammatory and anti-platelet therapy should be given; (2) PCI may cause myocardial injury, and which was related to the inflammation and platelet activation. (3)For the ACS patients who accepted regular atorvastatins treat-ment, high-dose (80mg) atorvastatin 12h before PCI has the effect on decreasing the level of sCD40L,hs-CRP,and reduce the incidence of periprocedural MI. (4)On the base of conventional atorvastatin treatment, preoperative 80mg atorvastatin intensive treatment didn’t show adverse effect.

Related Dissertations

  1. The Effects of Atorvastatin on Expression of Osteopontin in Kidney of the Diabetic Rats Its Molecular Mechanism,R587.2
  2. Antioxidant Effects of Atorvastatin on Vascular Remodeling of Vascular Injury in Mice,R543
  3. The Experimental Study of Atorvastatin with Neuroprotective Effects by Inhibiting MMP-9 and Upregulating TIMP-1 Expression in Rat Stroke Model of Focal Cerebral Ischemia/Reperfusion,R743.33
  4. Effect and Mechanism of Atorvastatin on Myocardial Fibrosis in Rats after Myocardial Infarction,R542.22
  5. Different Doses of Atorvastatin Improve the Forward Blood Flow in the No-reflow Rats Associated with Inflammation,R541
  6. Influence of Atrovastation on MMP-9 and TIMP-1 of Experimental Intracerebral Hemorrhage in Rats,R965
  7. Protective Effects of Atorvastatin on Vascular Endothelial Dysfunction Caused by Lysophosphatidyl Choline,R965
  8. The Effect of Zhibitai Combined with Atorvastatin on Lipoprotein Profiles and Inflammatory Factors in Patients with Coronary Heart Disease,R541.4
  9. The Gene Polymorphism and Serum Content of TNF-α in Restenosis Patients after PCI,R541.4
  10. Effect of Atorvastatin on the Concentration of Plasma Asymmetric Dimethylarginine in Acute Myocardial Infarction Patients during PCI Perioperative Period,R541.4
  11. Atorvastatin treatment of hypertensive intracerebral hemorrhage in rats Experimental study of mechanism of action,R965
  12. Research on the Effects of Atorvastation on Glucose Tolerance、Bone Metabolism in Rats and Its Mechanisms,R587.1
  13. Aging Changes of PPARα in Rat Hepatic and the Effect of Atorvastatin,R589.2
  14. Effects of Atorvastatin on the Expression of Nuclear Orphan Receptor Nur77 after Carotid Artery Balloon-Injury in Rats,R965
  15. Atorvastatin Pretreatment on Myocardial Ischemia-reperfusion Injury and Its Mechanism,R965
  16. Effect of CYP3AP1 and ABCC2 Gene Polymorphism on Lipid-lowering Efficacy of Atorvastatin,R589.2
  17. Effect of Different Dose of Atorvastatin on Short Term Renal Function and Myocardial Protection After Percutaneous Coronary Intervention on Patients with Acute Coronary Syndrome,R541.4
  18. The Effect of Atorvastatin on the Expression of (LOX-1) Mediated by Oxidized Low Density Lipoprotein(ox-LDL) in Cultured Human Umbilical Vein Endothelial Cells(ECV304),R543.5
  19. Effects of Atorvastatin on Ⅰto of the Simulated Ischemia Myocytes in Rat Left Ventricle,R965
  20. Effects of Earlier Statin Therapy on Inflammatory Factors in Patients with Acute Myocardial Infarction,R542.22

CLC: > Medicine, health > Internal Medicine > Heart, blood vessels ( circulatory ) disease > Heart disease > Coronary arteries ( atherosclerosis ),heart disease (CHD)
© 2012 www.DissertationTopic.Net  Mobile